CIK: 1456750 - Address: C/O Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark, CA 94560
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/17/23 19:24
4/13/23
CBAYCymabay Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKim Dennis DCAOChief MeM.dm5244.37012020D
4/17/23 19:24
4/13/23
CBAYCymabay Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKim Dennis DCAOChief MeS.dm-1,1409.500-120-8620D
3/30/23 17:39
3/28/23
CBAYCymabay Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKim Dennis DCAOChief MeM.d04.3700120D
3/30/23 17:39
3/28/23
CBAYCymabay Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKim Dennis DCAOChief MeS.d-18.9900020D
1/20/22 16:35
1/19/22
CBAYCymabay Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKim Dennis DCAOChief MeP613.04020New20D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact